A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Baxter International Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 544,800 shares of BAX stock, worth $17.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
544,800
Previous 361,900 50.54%
Holding current value
$17.8 Million
Previous $12.1 Million 70.89%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$32.85 - $40.26 $80.8 Million - $99.1 Million
-2,460,950 Reduced 86.47%
385,103 $14.6 Million
Q2 2024

Aug 14, 2024

BUY
$32.87 - $43.55 $93 Million - $123 Million
2,828,051 Added 15709.65%
2,846,053 $95.2 Million
Q1 2024

May 15, 2024

SELL
$37.88 - $43.77 $6.28 Million - $7.26 Million
-165,905 Reduced 90.21%
18,002 $769,000
Q4 2023

Feb 14, 2024

BUY
$31.71 - $38.95 $548,012 - $673,133
17,282 Added 10.37%
183,907 $7.11 Million
Q3 2023

Nov 14, 2023

SELL
$37.32 - $49.29 $132 Million - $175 Million
-3,547,990 Reduced 95.51%
166,625 $6.29 Million
Q2 2023

Aug 14, 2023

BUY
$39.98 - $47.68 $46.1 Million - $55 Million
1,153,043 Added 45.01%
3,714,615 $169 Million
Q1 2023

May 15, 2023

BUY
$37.58 - $52.57 $25.8 Million - $36.1 Million
686,408 Added 36.61%
2,561,572 $104 Million
Q4 2022

Feb 14, 2023

BUY
$49.7 - $57.71 $58.8 Million - $68.3 Million
1,183,313 Added 171.04%
1,875,164 $95.6 Million
Q3 2022

Nov 14, 2022

SELL
$53.86 - $66.8 $9.63 Million - $11.9 Million
-178,804 Reduced 20.54%
691,851 $37.3 Million
Q2 2022

Aug 15, 2022

SELL
$63.83 - $80.0 $10.9 Million - $13.6 Million
-170,342 Reduced 16.36%
870,655 $55.9 Million
Q1 2022

May 16, 2022

SELL
$76.85 - $89.45 $75.4 Million - $87.7 Million
-980,548 Reduced 48.5%
1,040,997 $80.7 Million
Q4 2021

Feb 14, 2022

BUY
$74.57 - $87.19 $29.7 Million - $34.7 Million
397,887 Added 24.51%
2,021,545 $174 Million
Q3 2021

Nov 15, 2021

BUY
$73.77 - $83.61 $91.9 Million - $104 Million
1,245,964 Added 329.89%
1,623,658 $131 Million
Q2 2021

Aug 16, 2021

BUY
$80.5 - $88.01 $26.3 Million - $28.7 Million
326,553 Added 638.53%
377,694 $30.4 Million
Q4 2020

Feb 16, 2021

SELL
$75.39 - $82.36 $32.4 Million - $35.4 Million
-430,201 Reduced 89.38%
51,141 $4.1 Million
Q3 2020

Nov 16, 2020

BUY
$78.33 - $90.73 $28.3 Million - $32.8 Million
361,834 Added 302.77%
481,342 $38.7 Million
Q2 2020

Aug 14, 2020

SELL
$78.66 - $94.14 $326 Million - $391 Million
-4,150,578 Reduced 97.2%
119,508 $10.3 Million
Q1 2020

May 15, 2020

SELL
$71.57 - $93.3 $88.9 Million - $116 Million
-1,241,714 Reduced 22.53%
4,270,086 $347 Million
Q4 2019

Feb 14, 2020

BUY
$76.7 - $88.45 $346 Million - $399 Million
4,511,252 Added 450.88%
5,511,800 $461 Million
Q3 2019

Nov 14, 2019

BUY
$81.4 - $89.78 $4.18 Million - $4.61 Million
51,346 Added 5.41%
1,000,548 $87.5 Million
Q2 2019

Aug 14, 2019

BUY
$73.44 - $82.41 $68.3 Million - $76.6 Million
929,635 Added 4751.03%
949,202 $77.7 Million
Q4 2018

Feb 14, 2019

SELL
$61.45 - $77.8 $17.4 Million - $22.1 Million
-283,621 Reduced 93.55%
19,567 $1.29 Million
Q3 2018

Nov 13, 2018

SELL
$70.71 - $77.75 $195 Million - $214 Million
-2,753,106 Reduced 90.08%
303,188 $0
Q2 2018

Aug 10, 2018

SELL
$63.43 - $75.41 $97 Million - $115 Million
-1,529,864 Reduced 33.36%
3,056,294 $0
Q1 2018

May 11, 2018

SELL
$62.56 - $72.26 $44.3 Million - $51.2 Million
-708,438 Reduced 13.38%
4,586,158 $298 Million
Q4 2017

Feb 09, 2018

BUY
$61.45 - $66.05 $224 Million - $241 Million
3,652,903 Added 222.51%
5,294,596 $342 Million
Q3 2017

Nov 09, 2017

BUY
$59.5 - $64.61 $97.7 Million - $106 Million
1,641,693
1,641,693 $103 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.4B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.